Free tool
FAERS Monitor: Lodoco
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215727 or its brand name (Lodoco, Colchicine). Reports on generic versions are filed under their own applications.
Reports
24
Serious
8
33% of reports
Hospitalization
2
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea4
- abdominal discomfort3
- pain3
- dizziness2
- fatigue2
- nausea2
- product use in unapproved indication2
- product use issue2
- abdominal pain1
- abdominal pain upper1
- adverse event1
- back pain1
- balance disorder1
- chronic obstructive pulmonary disease1
- colitis1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 9 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,135 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| colitis | 1 | 23.1 | 3.4 | 5 |
| chronic obstructive pulmonary disease | 1 | 16.8 | 2.5 | 3 |
| abdominal discomfortSignal | 3 | 15.7 | 5.4 | 28 |
| balance disorder | 1 | 10.1 | 1.5 | 2 |
| adverse event | 1 | 9.5 | 1.4 | 1 |
| product use issue | 2 | 9.3 | 2.5 | 8 |
| product use in unapproved indication | 2 | 7.1 | 1.9 | 5 |
| diarrhoeaSignal | 4 | 5.4 | 2.2 | 11 |
| painSignal | 3 | 4.3 | 1.5 | 5 |
| abdominal pain upper | 1 | 4.3 | 0.6 | 0 |
| back pain | 1 | 3.8 | 0.6 | 0 |
| abdominal pain | 1 | 3.8 | 0.6 | 0 |
| dizziness | 2 | 3.5 | 0.9 | 2 |
| fatigue | 2 | 2.3 | 0.6 | 0 |
| nausea | 2 | 2.2 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.